Tandem Diabetes Care Inc
TNDM· Nasdaq
Released Nov 1, 2018, after the close
10-Q filed Nov 1, 2018, 32 days after period end · 0001564590-18-026264
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $46.26M | $27.00M | $12.29M | $15.72M |
| Net Income | -$34.25M | -$16.03M | -$29.82M | -$19.59M |
| EPS Diluted |
Tandem Diabetes Care Inc · CIK 1438133 · Engraved from SEC EDGAR
| -$0.62 |
| -$3.09 |
| -$9.70 |
| -$0.65 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.